Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

CONTRIBUTING WRITER

Deepak Balak, MD, PhD, MSc
LangeLand Hospital and Ghent University Hospital
Zoetermeer, Netherlands
2019 Fellow

Dr. Balak works as a dermatologist at the Department of Dermatology of the LangeLand Hospital in Zoetermeer, the Netherlands and at the Department of Dermatology of the Ghent University Hospital in Ghent, Belgium, where he combines patient care with teaching responsibilities and research. His clinical interests are centered on the impact and management of inflammatory and autoimmune diseases. His scientific interests include translational medicine, and clinical drug development and evaluation in the field of chronic immune-mediated inflammatory skin diseases, such as psoriasis. As a 2019 Fellow, he studied with Dr. Alice Gottlieb at the Mount Sinai Hospital in New York, New York and attended the European Academy of Dermatology and Venereology Congress. During his time in New York, he was able to observe Dr. Gottlieb’s clinics with complex and therapy-recalcitrant cases of psoriasis and psoriatic arthritis. He joined residents in didactics programs and ground rounds as well as participated in ongoing psoriasis-research projects (IDEOM).

Last Updated: Aug 24, 2021

Latest news

September 13, 2021
Update on the PsoProtect Registry. PsoProtect is a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis. Data set currently includes 1,205 cases.
July 12, 2021
Update on the PsoProtect Registry. PsoProtect is a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis. Data set currently includes 1,147 cases.
July 07, 2021
IPC Councilor, Luigi Naldi, MD, shares his expert opinion on a population-based study of COVID-19 - associated hospitalization and mortality in patients with psoriasis.
June 21, 2021
The AbbVie program features IPC Board Member Bruce Strober’s Grand Rounds, a tutorial explaining the current method of measuring the severity of psoriasis, why this limits proper care and treatment for psoriasis patients, how IPC’s Disease Severity Reclassification Project solves these problems, and how clinicians can implement this new classification method.
More News

We use cookies on this site to enhance your online experience. By continuing to use this site, you agree to accept cookies.
OK